Golden State Equity Partners’s Ensysce Biosciences ENSC Stock Holding History

Golden State Equity Partners’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33	Buy	+80	New	+$30	﹤0.01%	2204

Other funds holding ENSC

StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Golden State Equity Partners's ENSC Position: Q3 2026 in Review

Golden State Equity Partners opened a new position in Ensysce Biosciences (ENSC) in Q3 2026: 80 shares worth $33. The stake represents ﹤0.01% of the portfolio and ranks #2204 among its holdings.

6 funds tracked by Wall St. Rank hold ENSC as of Q3 2026.

Golden State Equity Partners held 80 shares of Ensysce Biosciences worth $33 as of Q3 2026.
Ensysce Biosciences was a new Golden State Equity Partners position in Q3 2026.
Ensysce Biosciences made up ﹤0.01% of Golden State Equity Partners's portfolio in Q3 2026, its #2204 holding.
6 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q3 2026.

Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.